Cite
MLA Citation
P. Jain et al.. “Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use.” Lung cancer, vol. 139, n.d., pp. S46–. http://access.bl.uk/ark:/81055/vdc_100099355988.0x000041